Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cells|January 11, 2024
Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2Iqra Nazish, Adamantios Mamais, Anna Mallach, et al.
Journal of Neurochemistry|March 31, 2007
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1Elisa Greggio, Patrick A Lewis, Marcel P van der Brug, et al.
Nature Communications|December 16, 2014
Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7Ruth Chia, Sara Haddock, Alexandra Beilina, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2Iqra Nazish, Adamantios Mamais, Anna Mallach, et al.
Cells|October 27, 2020
Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse TissuesLucia Iannotta, Alice Biosa, Jillian H Kluss, et al.
The Journal of Biological Chemistry|April 10, 2008
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylationElisa Greggio, Ibardo Zambrano, Alice Kaganovich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodiesDaniel Erskine, Jinhui Ding, Alan J Thomas, et al.
Neurochemical Research|October 7, 2018
Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2Rebekah G Langston, Iakov N Rudenko, Ravindran Kumaran, et al.
Nature Communications|May 11, 2021
High-frequency head impact causes chronic synaptic adaptation and long-term cognitive impairment in miceStephanie S Sloley, Bevan S Main, Charisse N Winston, et al.
NPJ Parkinson'S Disease|July 19, 2022
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's diseaseMaria Kedariti, Emanuele Frattini, Pascale Baden, et al.
Pageof 4